Abstract:Eosinophil cationic proteins influence several biological functions of the respiratory epithelium, yet their direct contribution to airway remodeling has not been established. We show that incubation of the human bronchial epithelial cell line, BEAS-2B, or primary cultured human bronchial epithelial cells, normal human bronchial epithelial cells, with subcytotoxic concentrations (0.1, 0.3, and 1 μM) of major basic protein (MBP), or eosinophil peroxidase (EPO), augmented the transcripts of endothelin-1, TGF-α, … Show more
“…The level of sputum eosinophil plays an important role in airway remodeling in asthma (Pegorier et al 2006). Furthermore, eosinophil has been known to play a key role in the natural exacerbation caused by viral and non-viral agents in asthma (Hogan et al 2008).…”
Section: Discussionmentioning
confidence: 99%
“…Both the ECP and EPO reflect the disease activity in AR, and a study reported that the ECP and EPO were predictors of the development of asthma in AR patients (Nielsen et al 2009). One study has reported that the MBP and EPO were associated with the activation of the airway remodeling factor (Pegorier et al 2006).…”
Section: Discussionmentioning
confidence: 99%
“…Other studies have reported that eosinophil granule proteins in induced sputum or serum are higher in allergic diseases such as asthma or AR than in normal subjects (Sohn et al 2008;Hogan et al 2008) and were reflective of disease activities in AR or asthma (Nielsen et al 2009). Some investigators have suggested that eosinophil granule proteins are associated with the airway remodeling associated with these diseases (Pegorier et al 2006;Hogan et al 2008) and that they contribute to bronchoconstriction and airway hyperresponsiveness in asthma (Gundel et al 1991;Coyle et al 1993;Uchida et al 1993).…”
Section: Introductionmentioning
confidence: 99%
“…Many researchers have investigated the proportion of eosinophils and the expression of eosinophil granule proteins in the aforementioned eosinophilic airway diseases (Koh et al 2003;Badar et al 2004;Pegorier et al 2006;Sohn et al 2008;Hogan et al 2008). However, none of them investigated which is more important in the identification of the disease and disease activity: the extent of eosinophil activity, as reflected by the eosinophil granule protein concentration in induced sputum, the eosinophil cell count in serum or the proportion of eosinophils among the cells obtained from induced sputum.…”
Eosinophils are regarded as the major effector cells that produce symptoms in allergic diseases. Activation of eosinophils induces extracellular release of a number of eosinophil granule proteins, including major basic protein (MBP), eosinophil cationic protein (ECP), eosinophil peroxidase (EPO), and eosinophilderived neurotoxin. The objective of this study was to evaluate the differences and significance of the sputum eosinophil% and expression levels of eosinophilic granule protein mRNAs in allergic airway disease. Induced sputum samples were obtained from non-smokers with 25 asthma, 54 eosinophilic bronchitis, 16 allergic rhinitis, and 19 healthy control subjects. The eosinophil granule protein mRNAs were measured with real time RT-PCR. There was no correlation between the sputum eosinophil% and the mRNA level of any of eosinophil granule proteins. However, the expression levels of MBP and ECP mRNAs were higher in subjects with each of the specified allergic diseases than those in control subjects (P < 0.05). Moreover, in the subjects with allergic sensitization, the expression levels of MBP and EPO mRNAs were significantly higher in those with airway hyperresponsiveness (13 subjects) than in those without airway hyperresponsiveness (32 subjects) (P = 0.004 and 0.010, respectively). In asthma patients, the FEV1% was negatively correlated with ECP mRNA levels (r = −0.510, P = 0.022), but showed no correlation with sputum eosinophil%. In conclusion, mRNA levels of eosinophil granule proteins, rather than sputum eosinophil%, may reflect airway hyperresponsiveness and airflow limitation. In practice, consideration for the eosinophil% as well as the eosinophil granule proteins levels in induced sputum is needed.
“…The level of sputum eosinophil plays an important role in airway remodeling in asthma (Pegorier et al 2006). Furthermore, eosinophil has been known to play a key role in the natural exacerbation caused by viral and non-viral agents in asthma (Hogan et al 2008).…”
Section: Discussionmentioning
confidence: 99%
“…Both the ECP and EPO reflect the disease activity in AR, and a study reported that the ECP and EPO were predictors of the development of asthma in AR patients (Nielsen et al 2009). One study has reported that the MBP and EPO were associated with the activation of the airway remodeling factor (Pegorier et al 2006).…”
Section: Discussionmentioning
confidence: 99%
“…Other studies have reported that eosinophil granule proteins in induced sputum or serum are higher in allergic diseases such as asthma or AR than in normal subjects (Sohn et al 2008;Hogan et al 2008) and were reflective of disease activities in AR or asthma (Nielsen et al 2009). Some investigators have suggested that eosinophil granule proteins are associated with the airway remodeling associated with these diseases (Pegorier et al 2006;Hogan et al 2008) and that they contribute to bronchoconstriction and airway hyperresponsiveness in asthma (Gundel et al 1991;Coyle et al 1993;Uchida et al 1993).…”
Section: Introductionmentioning
confidence: 99%
“…Many researchers have investigated the proportion of eosinophils and the expression of eosinophil granule proteins in the aforementioned eosinophilic airway diseases (Koh et al 2003;Badar et al 2004;Pegorier et al 2006;Sohn et al 2008;Hogan et al 2008). However, none of them investigated which is more important in the identification of the disease and disease activity: the extent of eosinophil activity, as reflected by the eosinophil granule protein concentration in induced sputum, the eosinophil cell count in serum or the proportion of eosinophils among the cells obtained from induced sputum.…”
Eosinophils are regarded as the major effector cells that produce symptoms in allergic diseases. Activation of eosinophils induces extracellular release of a number of eosinophil granule proteins, including major basic protein (MBP), eosinophil cationic protein (ECP), eosinophil peroxidase (EPO), and eosinophilderived neurotoxin. The objective of this study was to evaluate the differences and significance of the sputum eosinophil% and expression levels of eosinophilic granule protein mRNAs in allergic airway disease. Induced sputum samples were obtained from non-smokers with 25 asthma, 54 eosinophilic bronchitis, 16 allergic rhinitis, and 19 healthy control subjects. The eosinophil granule protein mRNAs were measured with real time RT-PCR. There was no correlation between the sputum eosinophil% and the mRNA level of any of eosinophil granule proteins. However, the expression levels of MBP and ECP mRNAs were higher in subjects with each of the specified allergic diseases than those in control subjects (P < 0.05). Moreover, in the subjects with allergic sensitization, the expression levels of MBP and EPO mRNAs were significantly higher in those with airway hyperresponsiveness (13 subjects) than in those without airway hyperresponsiveness (32 subjects) (P = 0.004 and 0.010, respectively). In asthma patients, the FEV1% was negatively correlated with ECP mRNA levels (r = −0.510, P = 0.022), but showed no correlation with sputum eosinophil%. In conclusion, mRNA levels of eosinophil granule proteins, rather than sputum eosinophil%, may reflect airway hyperresponsiveness and airflow limitation. In practice, consideration for the eosinophil% as well as the eosinophil granule proteins levels in induced sputum is needed.
“…The levels of the transcripts encoding ChTRase were assessed by quantitative real-time PCR (Mx 3000P apparatus, Stratagene Europe, Amsterdam, The Netherlands), and their expression was normalized to that of ubiquitin C, using GeNorm software. 17 Primers (ChTRase, GenBank Identifier NM_003465, sense 5Ј-CTGCATCATGGTGCG-GTC-3Ј, antisense, 5Ј-GTGCTCAGCTGGTGGTTG-3Ј; ubiquitin C (GenBank Idenfier NM_004168), sense, 5Ј-CACTTGGTCCTGCGCTTGA-3Ј, antisense, 5Ј-TTTTGG-GAATGCAACAACTTT-3Ј) were designed using Primer Express 2 Software (Applied Biosystems, Framingham, MA) and were synthesized by Genosys (Sigma). Their sequences were blasted against Basic Local Alignment Search Tool database (http://www.ncbi.nlm.nih.gov/ BLAST).…”
Chronic obstructive pulmonary disease (COPD) is characterized by chronic airway inflammation and emphysematous alveolar destruction. In this study, we have investigated whether chitotriosidase (ChTRase) and acidic mammalian chitinase, two chitinases with chitinolytic activity, are selectively augmented in COPD and contribute to its pathogenesis. We found that smokers with COPD, but not asthmatics, had higher chitinolytic activity and increased levels of ChTRase in bronchoalveolar lavage, more ChTRasepositive cells in bronchial biopsies, and an elevated proportion of alveolar macrophages expressing ChTRase than smokers without COPD or never-smokers. ChTRase accounted for approximately 80% of bronchoalveolar lavage chitinolytic activity, while acidic mammalian chitinase was undetectable. Bronchoalveolar lavage chitinolytic activity and ChTRase were associated with airflow obstruction and emphysema and with the levels of interleukin (IL)؊1, IL-8, tumor-necrosis factor (TNF)-␣, and its type II soluble receptor. Tumor necrosis factor-␣ stimulated ChTRase release only from alveolar macrophages from smokers with COPD, and exposure of these cells to ChTRase promoted the release of IL-8, monocyte-chemoattractant protein-1, and metalloproteinase-9. Finally, ChTRase overexpression in the lung of normal mice promoted macrophage recruitment and the synthesis of the murine homologue of IL-8, keratinocyte-derived cytokine, and of monocyte-chemoattractant protein-1. We conclude that pulmonary ChTRase overexpression may represent a novel important mechanism involved in COPD onset and progression. (Am J
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.